key: cord-0726957-4y7lpag6
authors: Roth, Eliane; Noll, Georg; Gämperli, Oliver; Wenaweser, Peter; Wyss, Christophe; Grünenfelder, Jürg; Corti, Roberto; Biaggi, Patric
title: Percutaneous Tricuspid Valve Repair: A Promising Treatment for Heart Transplant Patients With Severe Tricuspid Regurgitation
date: 2021-08-19
journal: JACC Case Rep
DOI: 10.1016/j.jaccas.2021.05.018
sha: 7e4600f400b7cad61fcf4b0a35e9c4ee976b60cc
doc_id: 726957
cord_uid: 4y7lpag6

Two heart transplant patients aged 80 and 83 years with recurrent heart failure due to severe tricuspid regurgitation are reported. In view of their high perioperative risk, both patients underwent percutaneous transcatheter edge-to-edge tricuspid valve repair, and both experienced excellent technical success, with favorable 2-year clinical outcome. (Level of Difficulty: Advanced.)

T ricuspid regurgitation (TR) is one of the leading pathologies following longstanding orthotopic heart transplantation (OHT), with an incidence of 19% to 84%. The main etiologies are annular dilatation caused by atrial dilatation and iatrogenic regurgitation as a consequence of multiple endomyocardial biopsies with incidental biopsy of septal chords (1) . Severe TR is associated with increased morbidity and mortality. However, tricuspid valve (TV) surgery in OHT patients is also associated with high perioperative risk, and therefore, alternative treatment options are warranted (2) . We present 2 cases of elderly OHT patients with severe TR who underwent percutaneous treatment.

The 83-year-old patient was admitted for New York Heart Association functional class IV dyspnea, 29 years after OHT by bicaval technique for heart failure caused by dilatative cardiomyopathy. The patient had undergone 71 endomyocardial biopsies, with the most recent in 2018 showing no rejection. TR was first noticed 12 years after OHT. The baseline findings can be seen in Table 1 . Echocardiographic assessment and grading of TR were performed based on current guidelines (3) . In this patient, Doppler echocardiography revealed grade V TR (4) (torrential: mean biplane vena contracta of 13 mm, effective regurgitant orifice area of 0.88 cm 2 , and regurgitant flow of

To identify TR as the most common valvular disease after longstanding OHT with negative impact on morbidity and mortality. To understand that OHT patients with severe TR need evaluation by heart teams experienced in patient selection and the treatment (both interventional and surgical) of patients with complex valvular disease. To recommend transcatheter edge-to-edge repair for suitable high-risk OHT patients with severe TR because successful treatment may lead to favorable clinical outcome at up to 2 years. 78.6 mL) due to a combination of several flail septal leaflets (the result of erroneous biopsies of septal chords, with a septal-anterior coaptation gap of 8 mm) and severe right ventricle (RV) and right atrium dilatation (Table 1, Figure 1 ). Recent heart catheterization showed unobstructed inferior vena cava access, normal coronary status, and mild elevation of the pulmonary vascular resistance (333 dyne$s/cm 5 ) but normal systolic pulmonary artery pressure (31 mm Hg).

The 80-year-old patient was admitted for progressive and now severe lower-extremity edemas and dyspnea (New York Heart Association functional class III). At the age of 57 years, he underwent bicaval OHT for dilatative cardiomyopathy. A total of 80 endomyocardial biopsies had been performed. The first signs of right-sided heart failure due to TR were noted 16 years after OHT. His baseline findings can be seen in Table 2 . Echocardiography also demonstrated an iat- 

A U G U S T 2 0 2 1 : 1 2 6 9 -1 2 7 4 (54 mm Hg). Furthermore, mild but nonsignificant graft atherosclerosis was noted.

HEART TEAM ASSESSMENT, TREATMENT,

Our heart team board reviewed the patients, and both were found at high risk for surgical TV repair (Euro-Score II and STS scores: 12.8% and 9.9%, respectively Several factors must be met to achieve a favorable technical outcome using transcatheter TV repair.

Heart teams assessing and treating such patients must be specialized in many aspects, including clinical management of OHT patients, advanced imaging in this patient population regularly excluded from current trials to increase our understanding of patient selection for different treatment strategies. 

Tricuspid regurgitation after cardiac transplantation: an old problem revisited

Inhospital outcomes and trends of tricuspid valve surgery in heart transplant patients

Imaging assessment of tricuspid regurgitation severity

The need for a new tricuspid regurgitation grading scheme

Transcatheter tricuspid repair with MitraClip for severe primary tricuspid regurgitation

Edge-toedge tricuspid valve repair for severe tricuspid regurgitation 20 years after cardiac transplantation

Case report: transcatheter valve repair with Cardioband: a new treatment option for secondary tricuspid regurgitation in cardiac transplant patients

Heart team approach in treatment of mitral regurgitation: patient selection and outcome

Transcatheter edge-to-edge repair for treatment of tricuspid regurgitation